FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Mar 2024. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5290046012 | Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5290047015 | Balsam of Peru 18 mg/g and bismuth oxide 21.4 mg/g and zinc oxide 107.5 mg/g cutaneous cream | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | Cutaneous cream | true | Inferred relationship | Some | ||
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Balsam of Peru | true | Inferred relationship | Some | 1 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Balsam of Peru | true | Inferred relationship | Some | 1 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | This attribute specifies the numerator unit for the concentration strength of a product. | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | This attribute specifies the denominator unit for the concentration strength of a product. | g | true | Inferred relationship | Some | 1 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Bismuth oxide (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Bismuth oxide (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | This attribute specifies the numerator unit for the concentration strength of a product. | mg | true | Inferred relationship | Some | 2 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | This attribute specifies the denominator unit for the concentration strength of a product. | g | true | Inferred relationship | Some | 2 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Zinc oxide | true | Inferred relationship | Some | 3 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Zinc oxide | true | Inferred relationship | Some | 3 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | This attribute specifies the numerator unit for the concentration strength of a product. | mg | true | Inferred relationship | Some | 3 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | This attribute specifies the denominator unit for the concentration strength of a product. | g | true | Inferred relationship | Some | 3 | |
| Product containing precisely balsam of Peru 18 milligram/1 gram and bismuth oxide 21.4 milligram/1 gram and zinc oxide 107.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | Is a | Balsam of Peru and bismuth oxide and zinc oxide only product in cutaneous dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets